Exploratory Clinical Study on the Effectiveness of Glycyrrhizin in Early Vascular Lesions of Systemic Sclerosis - The Effectiveness of Glycyrrhizin in Systemic Sclerosis

The University of Tokyo0 个研究点目标入组 20 人开始时间: 2018年4月13日最近更新: 2023年11月20日

适应症

试验速览

暂无简介。

•1)Patients with aldosteronism, myopathy or hypokalemia 2)Patients with cirrhosis with more than 70 microgram/dL serum ammonia concentration 3)Patients less than 3 months after the final administration of the other test drugs or investigational drugs 4)Patients with more than 10 MRSS (modified Rodnan total skin thickness score) 5)Patients with not satisfy% VC 80% and % DLCO 70% in respiratory function test 6)Patients with eGFR less than 45 mL / min / 1.73 m2 7)Patients with more than RVSP>40mmHg pulmonary hypertension 8)Patients with complications of systemic lupus erythematosus or dermatomyositis 9)Patients with a history of malignant tumors 10)Patients with a history of severe hypersensitivity or anaphylactic reaction to the components of test drug 11)patient judged by doctor as inappropriate

发起方